Search Clinical Trials
583,298 trials
ID
Status
Phase
Title
Sponsor
NCT07570836
Safety and Preliminary Efficacy of hUCMSC-EVs in Interstitial Lung DiseaseShanghai Zhongshan HospitalNot Yet RecruitingPhase 1
NCT07570836Not Yet Recruiting
Phase 1
Safety and Preliminary Efficacy of hUCMSC-EVs in Interstitial Lung DiseaseShanghai Zhongshan Hospit...
NCT07569276
Effects of an Experimental Propolis Gel on Tooth Sensitivity Control and Post-bleaching Color Change: a Randomized Clinical TrialUniversidade Federal do ParaNot Yet RecruitingNot Applicable
NCT07569276Not Yet Recruiting
Not Applicable
Effects of an Experimental Propolis Gel on Tooth Sensitivity Control and Post-bl...Universidade Federal do P...
NCT07571668
Effects of Robotic Hand Therapy on Hand Function and Dexterity in Cerebral PalsyRiphah International UniversityNot Yet RecruitingNot Applicable
NCT07571668Not Yet Recruiting
Not Applicable
Effects of Robotic Hand Therapy on Hand Function and Dexterity in Cerebral PalsyRiphah International Univ...
NCT07571590
Effectiveness of a Self-Efficacy Based Educational Program on Glycemic Self-Monitoring, Diabetes Self-Management Knowledge, and Health-Related Quality of Life Among Adults With Type 2 Diabetes MellitusJerash Private UniversityNot Yet RecruitingNot Applicable
NCT07571590Not Yet Recruiting
Not Applicable
Effectiveness of a Self-Efficacy Based Educational Program on Glycemic Self-Moni...Jerash Private University
NCT07571902
Revised-Paravertebral Nerve Blocks for Enhanced Recovery After Stoma ClosureSixth Affiliated Hospital, Sun Yat-sen UniversityNot Yet RecruitingNot Applicable
NCT07571902Not Yet Recruiting
Not Applicable
Revised-Paravertebral Nerve Blocks for Enhanced Recovery After Stoma ClosureSixth Affiliated Hospital...
NCT07570576
Front-of-package Warning Labels for Sugar Content in Sugar-sweetened BeveragesChinese University of Hong KongNot Yet RecruitingNot Applicable
NCT07570576Not Yet Recruiting
Not Applicable
Front-of-package Warning Labels for Sugar Content in Sugar-sweetened BeveragesChinese University of Hon...
NCT07570355
Pterygopalatine Ganglion Stimulation for the Treatment of Geographic AtrophyShanghai Institute of Acupuncture, Moxibustion and MeridianNot Yet RecruitingNot Applicable
NCT07570355Not Yet Recruiting
Not Applicable
Pterygopalatine Ganglion Stimulation for the Treatment of Geographic AtrophyShanghai Institute of Acu...
NCT07569939
Evaluation of Treatments for Sore Throat Associated With Acute Pharyngitis and/or Viral TonsillitisUniversity Hospital, Clermont-FerrandNot Yet RecruitingNot Applicable
NCT07569939Not Yet Recruiting
Not Applicable
Evaluation of Treatments for Sore Throat Associated With Acute Pharyngitis and/o...University Hospital, Cler...
NCT07568704
Image Evaluation of Intalight Dream OCTA Scans With Optos FA & ICGA ImagesIntalight, IncRecruiting
NCT07568704Recruiting
—
Image Evaluation of Intalight Dream OCTA Scans With Optos FA & ICGA ImagesIntalight, Inc
NCT07570147
A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Single Ascending Doses of ABBV-1451 Infusions and Injections in Healthy Adult ParticipantsAbbVieNot Yet RecruitingPhase 1
NCT07570147Not Yet Recruiting
Phase 1
A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Single Asc...AbbVie
NCT07569458
Online Personalized Psychological Intervention for Patients With Heart Disease and Depression or Anxiety (MY-CHOICE)Aalborg University HospitalRecruitingNot Applicable
NCT07569458Recruiting
Not Applicable
Online Personalized Psychological Intervention for Patients With Heart Disease a...Aalborg University Hospit...
NCT07569328
Low-dose Colchicine for CABG Graft Failure PreventionBeijing Anzhen HospitalNot Yet RecruitingNot Applicable
NCT07569328Not Yet Recruiting
Not Applicable
Low-dose Colchicine for CABG Graft Failure PreventionBeijing Anzhen Hospital
NCT07570849
Chidamide Combined With Chemotherapy and Immunotherapy as First-line Treatment for Advanced Intrahepatic CholangiocarcinomaShanghai Zhongshan HospitalRecruitingPhase 2
NCT07570849Recruiting
Phase 2
Chidamide Combined With Chemotherapy and Immunotherapy as First-line Treatment f...Shanghai Zhongshan Hospit...
NCT07570082
Drug-Drug Interaction Study of Atumelnant in Healthy ParticipantsCrinetics Pharmaceuticals Inc.RecruitingPhase 1
NCT07570082Recruiting
Phase 1
Drug-Drug Interaction Study of Atumelnant in Healthy ParticipantsCrinetics Pharmaceuticals...
NCT07569926
Impact of Fluciclovine (18F) PET (Positron Emission Tomography) on the Management of Prostate Cancer Following Negative or Equivocal PSMA (Prostate-Specific Membrane Antigen) PET Imaging at the Time of Biochemical RecurrenceBlue Earth DiagnosticsNot Yet RecruitingPhase 4
NCT07569926Not Yet Recruiting
Phase 4
Impact of Fluciclovine (18F) PET (Positron Emission Tomography) on the Managemen...Blue Earth Diagnostics
NCT07570524
Predicting Response to Immunochemotherapy in Early Triple Negative Breast CancerCenter Eugene MarquisNot Yet Recruiting
NCT07570524Not Yet Recruiting
—
Predicting Response to Immunochemotherapy in Early Triple Negative Breast CancerCenter Eugene Marquis
NCT07571369
Stress Modulation and Dynamic BalanceKafrelsheikh UniversityNot Yet RecruitingNot Applicable
NCT07571369Not Yet Recruiting
Not Applicable
Stress Modulation and Dynamic BalanceKafrelsheikh University
NCT07570589
An Observational, Prospective, Multicenter, Open-label Study to Monitor the Evolution of Myasthenia Gravis Symptoms in Real-life in Patients With Anti-AChR and Anti-MUSK Generalised Myasthenia Gravis in Therapy With RYSTIGGO® (Rozanolixizumab)Centre Hospitalier Universitaire de NiceNot Yet Recruiting
NCT07570589Not Yet Recruiting
—
An Observational, Prospective, Multicenter, Open-label Study to Monitor the Evol...Centre Hospitalier Univer...
NCT07568756
Utilization of Flotufolastat 18F PET for Post-Focal Therapy Prostate Cancer EvaluationBlue Earth DiagnosticsNot Yet RecruitingPhase 2
NCT07568756Not Yet Recruiting
Phase 2
Utilization of Flotufolastat 18F PET for Post-Focal Therapy Prostate Cancer Eval...Blue Earth Diagnostics
Result Breakdown
Not yet recruiting15 (75%)
Recruiting4 (20%)
Completed1 (5%)
not_applicable11 (55%)
Phase 13 (15%)
Not Specified3 (15%)
Phase 22 (10%)
Phase 41 (5%)